IMMUTEP LIMITED - AMER
2.0500
07-October-24 15:59:57
15 minutes delayed
Stocks
0.0000
0.00%
Today's range
2.0200 - 2.0900
ISIN
N/A
Source
NASDAQ
-
Immutep to Participate in Two Upcoming Investor Conferences
01 Nov 2022 19:59:04 By Nasdaq GlobeNewswire
-
26 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report
25 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
05 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
04 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Immutep to Participate in Two Upcoming Investor Conferences
26 Sep 2022 08:00:02 By Nasdaq GlobeNewswire
-
Immutep Receives A$2.7 million R&D Tax Incentive from French Government
23 Sep 2022 08:00:00 By Nasdaq GlobeNewswire
-
14 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
Immutep Appoints LAG-3 Pioneer, Frédéric Triebel to Board
13 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
06 Sep 2022 08:00:03 By Nasdaq GlobeNewswire
-
30 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report
28 Jul 2022 08:00:02 By Nasdaq GlobeNewswire
-
06 Jul 2022 08:00:02 By Nasdaq GlobeNewswire
-
Immutep to Announce New TACTI-002 Data at the 2022 World Conference on Lung Cancer
27 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
03 Jun 2022 14:18:08 By Nasdaq GlobeNewswire
-
Immutep Global Webcast to Discuss TACTI-002 Data Presented at ASCO 2022
02 Jun 2022 08:00:03 By Nasdaq GlobeNewswire
-
Immutep Announces Publication of TACTI-002 and TACTI-003 Abstracts at ASCO 2022
27 May 2022 08:00:00 By Nasdaq GlobeNewswire
-
Immutep to Present at Investor Conferences
20 May 2022 08:00:00 By Nasdaq GlobeNewswire
-
Immutep Appoints Leading Oncologists to its Clinical Advisory Board
18 May 2022 08:00:01 By Nasdaq GlobeNewswire
-
Immutep Presents New and Significant Data from the AIPAC Study
04 May 2022 08:00:02 By Nasdaq GlobeNewswire